Literature DB >> 528058

Disproportionate elevation of the immunoglobulin G1 concentration in cerebrospinal fluids of patients with multiple sclerosis.

W P Kaschka, L Theilkaes, K Eickhoff, F Skvaril.   

Abstract

We determined immunoglobulin G (IgG) subclass concentrations and studied their distributions in the cerebrospinal fluids of patients suffering from multiple sclerosis, other inflammatory neurological diseases, and non-inflammatory diseases of the nervous system in comparison with a control group. In addition, the four subclass concentrations were measured in serum specimens of the multiple sclerosis and control groups. These data were correlated with the extent of local IgG synthesis in the subarachnoid spaces of the patients belonging to the different groups. We found a selective elevation of the IgG1 subclass in the cerebrospinal fluids of multiple sclerosis patients, and there was only a very small overlap of the IgG1 ranges of the multiple sclerosis and control groups. No major differences were detected between the IgG subclass distributions in different courses of multiple sclerosis nor between multiple sclerosis and control sera. The group with non-inflammatory diseases showed a uniform elevation of all four subclasses and a greater overlap with the normal range. This latter feature was combined with an elevated IgG1 concentration in the group with other inflammatory diseases. It is concluded that locally synthesized IgG in the cerebrospinal fluids of multiple sclerosis patients consists mainly of IgG1.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 528058      PMCID: PMC414709          DOI: 10.1128/iai.26.3.933-941.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS.

Authors:  G A SCHUMACHER; G BEEBE; R F KIBLER; L T KURLAND; J F KURTZKE; F MCDOWELL; B NAGLER; W A SIBLEY; W W TOURTELLOTTE; T L WILLMON
Journal:  Ann N Y Acad Sci       Date:  1965-03-31       Impact factor: 5.691

2.  [Studies with gamma globulin labeled with radioiodine on the origin of protein bodies in the cerebrospinal fluid].

Authors:  E FRICK; L SCHEID-SEYDEL
Journal:  Klin Wochenschr       Date:  1958-09-15

3.  Antiviral antibody reacting on the plasma membrane alters measles virus expression inside the cell.

Authors:  R S Fujinami; M B Oldstone
Journal:  Nature       Date:  1979-06-07       Impact factor: 49.962

4.  Bound and free light chains in subacute sclerosing panencephalitis and multiple sclerosis serum and cerebrospinal fluid.

Authors:  F Bollengier; A Lowenthal; W Henrotin
Journal:  Z Klin Chem Klin Biochem       Date:  1975-07

5.  Aberrant CSF protein fractions found by electrofocusing in multiple sclerosis. A study of 26 cases with clinically verified or probable multiple sclerosis and 2 cases with optic neuritis.

Authors:  K G Kjellin; A Siden
Journal:  Eur Neurol       Date:  1977       Impact factor: 1.710

6.  Discrimination of elevated immunoglobulin concentrations in CSF due to inflammatory reaction of the central nervous system and blood-brain-barrier dysfunction.

Authors:  K Eickhoff; R Heipertz
Journal:  Acta Neurol Scand       Date:  1977-12       Impact factor: 3.209

7.  Molecular association between transplantation antigens and cell surface antigen in adenovirus-transformed cell line.

Authors:  S Kvist; L Ostberg; H Persson; L Philipson; P A Peterson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-11       Impact factor: 11.205

8.  Oligoclonal measles virus-specific IgG antibodies isolated from cerebrospinal fluids, brain extracts, and sera from patients with subacute sclerosing panencephalitis and multiple sclerosis.

Authors:  B Vandvik; E Norrby; H J Nordal; M Degré
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

9.  Oligoclonal immunoglobulins in subacute sclerosing panencephalitis and multiple sclerosis: a study of idiotypic determinants.

Authors:  G C Ebers; J B Zabriskie; H G Kunkel
Journal:  Clin Exp Immunol       Date:  1979-01       Impact factor: 4.330

10.  Cerebrospinal fluid immunoglobulin quotients, kappa/lambda ratios, and viral antibody titres in neurological disease.

Authors:  P J Roberts-Thomson; M M Esiri; A C Young; I C Maclennan
Journal:  J Clin Pathol       Date:  1976-12       Impact factor: 3.411

View more
  12 in total

Review 1.  Towards HIV-1 remission: potential roles for broadly neutralizing antibodies.

Authors:  Ariel Halper-Stromberg; Michel C Nussenzweig
Journal:  J Clin Invest       Date:  2016-01-11       Impact factor: 14.808

2.  A translational platform PBPK model for antibody disposition in the brain.

Authors:  Hsueh-Yuan Chang; Shengjia Wu; Guy Meno-Tetang; Dhaval K Shah
Journal:  J Pharmacokinet Pharmacodyn       Date:  2019-05-21       Impact factor: 2.745

3.  Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env protein.

Authors:  François Curtin; Hervé Perron; Arno Kromminga; Hervé Porchet; Alois B Lang
Journal:  MAbs       Date:  2015       Impact factor: 5.857

4.  Humoral immune response in Epstein-Barr virus infections. I. Elevated serum concentration of the IgG1 subclass in infectious mononucleosis and nasopharyngeal carcinoma.

Authors:  W P Kaschka; R Hilgers; F Skvaril
Journal:  Clin Exp Immunol       Date:  1982-07       Impact factor: 4.330

5.  Antibody to myelin basic protein in extracts of multiple sclerosis brain.

Authors:  C C Bernard; V B Randell; L B Horvath; P R Carnegie; I R Mackay
Journal:  Immunology       Date:  1981-07       Impact factor: 7.397

Review 6.  Biodistribution mechanisms of therapeutic monoclonal antibodies in health and disease.

Authors:  Mohammad Tabrizi; Gadi Gazit Bornstein; Hamza Suria
Journal:  AAPS J       Date:  2009-11-19       Impact factor: 4.009

7.  Total, anti-viral, and anti-myelin IgG subclass reactivity in inflammatory diseases of the central nervous system.

Authors:  T Mathiesen; H von Holst; S Fredrikson; G Wirsén; B Hederstedt; E Norrby; V A Sundqvist; B Wahren
Journal:  J Neurol       Date:  1989-05       Impact factor: 4.849

8.  Multiple sclerosis: subclasses of intrathecally synthesized IgG and measles and varicella zoster virus IgG antibodies.

Authors:  F Vartdal; B Vandvik
Journal:  Clin Exp Immunol       Date:  1983-12       Impact factor: 4.330

9.  Humoral immune response in Epstein-Barr virus infections. II. IgG subclass distribution in African patients with Burkitt's lymphoma and nasopharyngeal carcinoma.

Authors:  W P Kaschka; G Klein; R Hilgers; F Skvaril
Journal:  Clin Exp Immunol       Date:  1984-01       Impact factor: 4.330

10.  Lumbar and ventricular CSF concentrations of extracellular matrix proteins before and after shunt surgery in idiopathic normal pressure hydrocephalus.

Authors:  Karolina Minta; Anna Jeppsson; Gunnar Brinkmalm; Erik Portelius; Henrik Zetterberg; Kaj Blennow; Mats Tullberg; Ulf Andreasson
Journal:  Fluids Barriers CNS       Date:  2021-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.